Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.

Luciano Wannesson, Lisa Wang, John Kuruvilla, Tracy Nagy, Ronnie Saragosa, Norman Franke, Armand Keating, Michael Crump

Blood (2009) 114 (22): 3226.

https://doi.org/10.1182/blood.V114.22.3226.3226

Published: 2009

Journal Articles

Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.

Lisa Hicks, Joseph M. Connors, Joy Mangel, Rena Buckstein, Michael Crump, Heather Leitch, Kevin Imrie, Tracy Nagy, Angela Boudreau, Nancy Pennell, David Spaner, Neil Berinstein

Blood (2006) 108 (11): 3051.

https://doi.org/10.1182/blood.V108.11.3051.3051

Published: 2006

Journal Articles

Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients > 60 Versus ≤ 60 Years of Age.

John Kuruvilla, MD, Vikas Gupta, MD, Yael Zaretsky, MD, Sahar Zadeh, Tracy Nagy, Armand Keating, MD, Michael Crump, MD

Blood (2006) 108 (11): 3068.

https://doi.org/10.1182/blood.V108.11.3068.3068

Published: 2006

Journal Articles

Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL).

John Kuruvilla, MD, Tracy Nagy, Melania Pintilie, Armand Keating, MD, Michael Crump, MD

Blood (2005) 106 (11): 2085.

https://doi.org/10.1182/blood.V106.11.2085.2085

Published: 2005

Journal Articles

GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma.

John Kuruvilla, MD, Tracy Nagy, Melania Pintilie, Armand Keating, MD, Michael Crump, MD

Blood (2004) 104 (11): 905.

https://doi.org/10.1182/blood.V104.11.905.905

Published: 2004

Journal Articles

A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure.

Christine I. Chen, MD, Tracy Nagy, Qi-long Yi, Armand Keating, MD, Michael Crump, MD

Blood (2004) 104 (11): 2883.

https://doi.org/10.1182/blood.V104.11.2883.2883

Published: 2004

NARROW

Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.

Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.

Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients > 60 Versus ≤ 60 Years of Age.

Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL).

GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma.

A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure.

Email alerts

ASH Publications

American Society of Hematology

Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.

Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.

Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients > 60 Versus ≤ 60 Years of Age.

Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL).

GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma.

A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only